Switch to unified view

a b/Manuscripts/CDS-Bevacizumab-LLMs/README.md
1
<div align="left">
2
3
<br>
4
  
5
Kawchak K. Clinical decision support based on Bevacizumab cancer trials and pushing the limitations of advanced LLMs. Zenodo. 2025; doi:10.5281/zenodo.14968162 This content is a preprint and has not been peer-reviewed. Creative Commons Attribution 4.0 International.
6
7
[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.14968162.svg)](https://doi.org/10.5281/zenodo.14968162)
8
9
10
11
<div align="left">
12
13
<br>
14
  
15
Kawchak K. Gemini Update Clinical decision support based on Bevacizumab cancer trials and pushing the limitations of advanced LLMs. Zenodo. 2025; doi:10.5281/zenodo.14968289 This content is a preprint and has not been peer-reviewed. Creative Commons Attribution 4.0 International. [Full Study](https://doi.org/10.5281/zenodo.14968162)
16
17
[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.14968289.svg)](https://doi.org/10.5281/zenodo.14968289)
18
19
20
21
22
## AI Applications for Drug Industry
23
LLM and LLM agent pharmaceutical industry applications
24
25
[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.13273141.svg)](https://doi.org/10.5281/zenodo.13273141)